High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion

High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion

Abstract A deeper understanding of COVID‐19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)‐based proteomics to measure serum proteomes of COVID‐19 patients and symptomatic, but...

Full description

Bibliographic Details
Main Authors: Philipp E Geyer, Florian M Arend, Sophia Doll, Marie‐Luise Louiset, Sebastian Virreira Winter, Johannes B Müller‐Reif, Furkan M Torun, Michael Weigand, Peter Eichhorn, Mathias Bruegel, Maximilian T Strauss, Lesca M Holdt, Matthias Mann, Daniel Teupser
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:EMBO Molecular Medicine
Subjects:
biobanking
biomarker
immunoglobulins
individual‐specific
SARS‐CoV‐2
Online Access:https://doi.org/10.15252/emmm.202114167

Internet

https://doi.org/10.15252/emmm.202114167

Similar Items